Evidence map›Paper›PMID 35600767›Full record

ArticleJournal of ginseng research2022

Antidepressant-like effect of ginsenoside Rb1 on potentiating synaptic plasticity via the miR-134-mediated BDNF signaling pathway in a mouse model of chronic stress-induced depression.

Guoli Wang, Tianyue An, Cong Lei, Xiaofeng Zhu, Li Yang, Lianxue Zhang, Ronghua Zhang

Open access · goldAbstract read
In one paragraph

Article in Journal of ginseng research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 2 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 2 syntheses or guidelines pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Molecular medicine reports · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Exploring theJournal of ginseng research · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Guoli WangCollege of Pharmacy, Jinan University, Guangzhou, China.
Tianyue AnCollege of Pharmacy, Jinan University, Guangzhou, China.
Cong LeiCollege of Pharmacy, Jinan University, Guangzhou, China.
Xiaofeng ZhuCollege of Traditional Chinese Medicine, Jinan University, Guangzhou, China.
Li YangCollege of Pharmacy, Jinan University, Guangzhou, China.
Lianxue ZhangCollege of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, China.
Ronghua ZhangCollege of Pharmacy, Jinan University, Guangzhou, China.
Jinan University · CNJilin Agricultural University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Brain-derived neurotrophic factor (BDNF)-tropomyosin-related kinase B (TrkB) plays a critical role in the pathogenesis of depression by modulating synaptic structural remodeling and functional transmission. Previously, we have demonstrated that the ginsenoside Rb1 (Rb1) presents a novel antidepressant-like effect via BDNF-TrkB signaling in the hippocampus of chronic unpredictable mild stress (CUMS)-exposed mice. However, the underlying mechanism through which Rb1 counteracts stress-induced aberrant hippocampal synaptic plasticity via BDNF-TrkB signaling remains elusive. Methods: We focused on hippocampal microRNAs (miRNAs) that could directly bind to Results: Herein, we observed that brain-specific miRNA-134 (miR-134) could directly bind to Conclusion: These data provide strong evidence that Rb1 rescued CUMS-induced depression-like effects by modulating hippocampal synaptic plasticity via the miR-134-mediated BDNF signaling pathway.

Indexed as

AAV9, adeno-associated viral serotype 9AKT, protein kinase BAMPAR, α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptorANOVA, analysis of varianceBDNF, brain-derived neurotrophic factorBDNF–TrkB signalingCaMKII, Ca2+/calmodulin-dependent protein kinase IICMC-Na, carboxymethyl cellulose sodiumCREB, cAMP response element-binding proteinCUMS, chronic unpredictable mild stressDepressionDG, dentate gyrusERK1/2, extracellular regulatory protein kinasefEPSPs, field excitatory postsynaptic potentialsFST, forced swimming testGAP-43, growth-associated protein 43Ginsenoside Rb1GluR1, AMPAR subunit glutamate receptor 1GSK-3β, glycogen synthase kinase-3βHFS, high-frequency stimulationIACUC, Institutional Animal Care and Use CommitteeICR, Institute of Cancer Researchi.g., intragastricallyLIMK1, LIM-kinase 1LTD, long-term depressionLTP, long-term potentiationMAP-2, microtubule-associated protein-2MAPK, mitogen-activated protein kinaseMDD, major depressive disordermiR-134miR-134, miRNA-134miRNAs, microRNAsNeuN, neuronal nucleiNMDAR, N-methyl-D-aspartic acid receptorNR2A, NMDAR subunit 2ANR2B, NMDAR subunit 2BOFT, open field testPI3K, phosphatidylinositol 3-kinasePSD-95, postsynaptic density protein 95PSD, postsynaptic densityqRT-PCR, quantitative real-time PCRRb1, ginsenoside Rb1SEM, standard error of the meanSPT, sucrose preference testSynaptic plasticitySyn, synaptophysinTrkB, tropomyosin-related kinase BTST, tail suspension test

Identifiers

PMID35600767
PMCPMC9120625
OpenAlexW3137686578

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.